Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

489
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
489
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

913
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
913
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

379
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
379
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

374
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
374
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

594
The pathophysiology of pneumonia involves the following steps:
594
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

342
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
342

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage-specific therapy blocks the lung's mechanosensitive immune response to alveolar distension.

JCI insight·2025
Same author

Studying the Pulmonary Endothelium in Health and Disease: An Official American Thoracic Society Workshop Report.

American journal of respiratory cell and molecular biology·2024
Same author

Life-saving effect of pulmonary surfactant in premature babies.

The Journal of clinical investigation·2024
Same author

The pathogenesis of influenza in intact alveoli: virion endocytosis and its effects on the lung's air-blood barrier.

Frontiers in immunology·2024
Same author

Rescue of alveolar wall liquid secretion blocks fatal lung injury due to influenza-staphylococcal coinfection.

The Journal of clinical investigation·2023
Same author

Mitochondria of lung venular capillaries mediate lung-liver cross talk in pneumonia.

American journal of physiology. Lung cellular and molecular physiology·2023
Same journal

Heart-Specific Spinal and Vagal Afferents: Transcriptomic Signatures and Optogenetically Modulated Functional Coupling With Cardiomyocytes.

Comprehensive Physiology·2026
Same journal

The Adipose-Organ Communication Network in Clinical Obesity: From Adiposopathy to Systemic Metabolic Failure.

Comprehensive Physiology·2026
Same journal

Insight Into the Biological Link Between Novel Adiposity Indices and Incident Heart Failure.

Comprehensive Physiology·2026
Same journal

Domino Effect of the Kynurenine Pathway: Systemic Homeostasis, Metabolic Crosstalk, and Therapeutic Potential.

Comprehensive Physiology·2026
Same journal

Lung Pericytes: Molecular Mechanisms, Signaling Pathways, and Roles in Pulmonary Diseases.

Comprehensive Physiology·2026
Same journal

Sleep Disturbances and Male Reproductive Dysfunction: Pathophysiological Mechanisms Linking Obstructive Sleep Apnea and Sleep Deprivation.

Comprehensive Physiology·2026
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

25.5K

Leptin and Acute Lung Disorders.

Alice Huertas1, Jahar Bhattacharya2

  • 1Université Paris-Saclay, School of Medicine, DYNAMIC Lab, Le Kremlin-Bicêtre, France.

Comprehensive Physiology
|July 10, 2025
PubMed
Summary
This summary is machine-generated.

Leptin, a hormone involved in metabolism, has a complex role in lung health and acute respiratory distress syndrome (ARDS). Its effects on lung immunity and inflammation are still being investigated, especially concerning obesity.

Keywords:
JAK–STAT pathwayacute lung injuryacute respiratory distress syndromehyperleptinemiaobesity paradox

More Related Videos

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

11.9K
Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

6.1K

Related Experiment Videos

Last Updated: Sep 16, 2025

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

25.5K
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

11.9K
Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

6.1K

Area of Science:

  • Endocrinology
  • Immunology
  • Pulmonology

Background:

  • Leptin, primarily from white adipose tissue, regulates metabolism, immunity, and inflammation.
  • Leptin also acts as a cytokine-like hormone in the lungs, modulating immune responses via ObR receptor and JAK-STAT3/PI3K pathways.
  • Leptin influences lung maturation and alveolar development.

Purpose of the Study:

  • To explore the controversial role of leptin in acute lung disorders, particularly acute respiratory distress syndrome (ARDS).
  • To investigate the "obesity paradox" in ARDS, where obesity may confer protection.
  • To clarify leptin's impact on lung inflammation and its interaction with metabolic disorders.

Main Methods:

  • Review of existing literature on leptin's function in lung physiology and pathology.
  • Analysis of studies investigating the "obesity paradox" in ARDS.
  • Examination of conflicting animal model data on leptin's role in acute lung injury (ALI).

Main Results:

  • Leptin's role in ARDS is debated; some evidence suggests obesity-related hyperleptinemia may be protective.
  • Potential protective mechanisms include immune modulation, enhanced neutrophil recruitment, and improved macrophage function.
  • Obesity-induced leptin resistance may counteract potential benefits, and animal studies show conflicting results regarding leptin's effect on lung injury.

Conclusions:

  • Leptin's precise role in lung inflammation and ARDS requires further elucidation.
  • Understanding leptin's interplay with metabolic disorders like obesity is crucial for developing targeted ARDS therapies.
  • Further research is needed to resolve conflicting findings and establish leptin's therapeutic potential in pulmonary diseases.